Patients with second primary cancer, except:adequately treated non-melanoma skin cancer, curatively treated in-situ cancer of the cervix, or other solid tumor curatively treated with no evidence of disease for <= 5 years.
Has known active central nervous system(CNS) metastases
Has an active infection requiring systemic therapy
Pregnancy or breast feeding
Patients with cardiac problem
Any previous treatment with sunitinib
